Gasdermin D and Beyond - Gasdermin-mediated Pyroptosis in Bacterial Infections.
J Mol Biol
; 434(4): 167409, 2022 Feb 28.
Article
in English
| MEDLINE | ID: covidwho-1587212
ABSTRACT
The discovery of pyroptosis and its subsequent implications in infection and immunity has uncovered a new angle of host-defence against pathogen assault. At its most simple, gasdermin-mediated pyroptosis in bacterial infection would be expected to remove pathogens from the relative safety of the cytosol or pathogen containing vacuole/phagosome whilst inducing a rapid and effective immune response. Differences in gasdermin-mediated pyroptosis between cell types, stimulation conditions, pathogen and even animal species, however, make things more complex. The excessive inflammation associated with the pathogen-induced gasdermin-mediated pyroptosis contributes to a downward spiral in sepsis. With no currently approved effective treatment options for sepsis understanding how gasdermin-mediated pyroptotic pathways are regulated provides an opportunity to identify novel therapeutic candidates against this complex disease. In this review we cover recent advances in the field of gasdermin-mediated pyroptosis with a focus on bacterial infection and sepsis models in the context of humans and other animal species. Importantly we also consider why there is considerable redundancy set into these ancient immune pathways.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Bacterial Infections
/
Sepsis
/
Phosphate-Binding Proteins
/
Pore Forming Cytotoxic Proteins
/
Pyroptosis
Limits:
Animals
/
Humans
Language:
English
Journal:
J Mol Biol
Year:
2022
Document Type:
Article
Affiliation country:
J.jmb.2021.167409
Similar
MEDLINE
...
LILACS
LIS